Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis (Q44754660)
Jump to navigation
Jump to search
scientific article published in April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis |
scientific article published in April 2011 |
Statements
1 reference
Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis (English)
1 reference
Per Soelberg Sørensen
1 reference
Gavin Giovannoni
1 reference
Stuart Cook
1 reference
Kottil Rammohan
1 reference
Peter Rieckmann
1 reference
Patrick Vermersch
1 reference
Anthony Hamlett
1 reference
Vissia Viglietta
1 reference
Steven Greenberg
1 reference
CLARITY study group
1 reference
1 April 2011
1 reference
1 reference
Identifiers
1 reference